Skip to NavigationSkip to content

GSK offers concessions ahead of planned venture with Pfizer

Published on 21/06/19 at 09:14am

The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint venture with Pfizer’s consumer health business.

The EU competition enforcer will make its decision as to whether to accept the proposed merger, demand further concessions or open a full-scale investigation into the deal, by 10 July.

The concessions come as GSK began to sell off some of its consumer healthcare products ahead of the folding of its consumer healthcare brands into a joint venture with Pfizer. The deal was announced in December last year.

The agreement will see the two firms form a “premier global consumer healthcare company.” Pfizer will own 32% of the new consumer healthcare business. GSK will own the rest.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches